Insights Into Keros Therapeutics Inc (KROS) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Keros Therapeutics To Present at Pulmonary Vascular Research Institute 2024 Annual Congress.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Keros Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Keros Therapeutics Inc is $2.34B. A total of 0.43 million shares were traded on the day, compared to an average of 460.86K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, KROS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 3 BUYs and 5 SELLs from insiders. Insiders purchased 44,000 shares during that period but sold 40,000.

In the most recent transaction, Regnante Keith sold 40,000 shares of KROS for 45.29 per share on Nov 04. After the transaction, the Chief Financial Officer now owns 0 company shares. In a previous transaction on Jun 09, Regnante Keith sold 20,000 shares at 45.42 per share. KROS shares that Chief Financial Officer owns now total 0.

Among the insiders who sold shares, Regnante Keith disposed of 20,000 shares on Jun 08 at a per-share price of $47.79. This resulted in the Chief Financial Officer holding 0 shares of KROS after the transaction.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for KROS in the last 3 months, the mean price target is $82.30 with high estimates of $105.00 and low estimates of $60.00. In terms of 52-week highs and lows, KROS has a high of $66.98 and a low of $27.02.

As of this writing, KROS has an earnings estimate of -$1.37 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of -$1.22 per share and a lower estimate of -$1.53. The company reported an EPS of -$1.27 in the last quarter, which was 5.20% higher than expectations of -$1.34.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. KROS’s latest balance sheet shows that the firm has $230.04M in Cash & Short Term Investments as of fiscal 2021. There were $1.09M in debt and $11.85M in liabilities at the time. Its Book Value Per Share was $9.97, while its Total Shareholder’s Equity was $243.17M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KROS is Buy with a score of 5.00.

Most Popular

Related Posts